Literature DB >> 2591223

Cell metabolism in patients undergoing major valvular heart surgery: relationship with intra and postoperative hemodynamics, oxygen transport, and oxygen utilization patterns.

E Fiaccadori1, A Vezzani, E Coffrini, A Guariglia, N Ronda, G Tortorella, P Vitali, S Pincolini, C Beghi, F Fesani.   

Abstract

The relationships between cell metabolism and both hemodynamics and oxygen transport/utilization (VO2/DO2) pattern were evaluated intra and postoperatively in eight patients undergoing major valvular heart surgery with the aid of moderately hypothermic cardiopulmonary bypass (CPB). Quadriceps femoris specimens were obtained by the needle biopsy technique for muscle ATP, ADP, AMP, phosphocreatine (PCr), creatine and lactate determination at anesthesia induction, after CPB, as well as in the ICU 18 h after surgery. Moreover, hemodynamic variables, oxygen transport and utilization indices, and plasma lactate were measured at the same intervals and throughout the CPB period. After CPB, muscle ATP and PCr contents were reduced (p less than .05) as compared to those of both pre-CPB patients and healthy control subjects; muscle and plasma lactate levels were increased (p less than .05). Mean VO2 and DO2 values measured during CPB significantly decreased (p less than .05), but VO2 reduction was proportionally greater than that of DO2 (-62% vs. -41%). No correlation was found between VO2 and DO2 at that time, but a significant relationship (p less than .05) was found at the end of CPB. A further decrease in muscle ATP and PCr levels was measured in the ICU, as muscle and plasma lactate levels were still elevated. At that time, VO2 and DO2 were not significantly different from pre-CPB values, but were significantly (p less than .05) correlated with each other.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2591223     DOI: 10.1097/00003246-198912000-00008

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  7 in total

1.  Effect of extracorporeal life support on cerebral blood flow, metabolism and electrophysiology in normothermic cats.

Authors:  T Iijima; T Back; K A Hossmann
Journal:  Intensive Care Med       Date:  1995-01       Impact factor: 17.440

2.  Brain resuscitation by extracorporeal circulation after prolonged cardiac arrest in cats.

Authors:  T Iijima; R Bauer; K A Hossmann
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

3.  Initial postoperative serum lactate levels predict survival in children after open heart surgery.

Authors:  L B Siegel; H J Dalton; J H Hertzog; R A Hopkins; R L Hannan; G J Hauser
Journal:  Intensive Care Med       Date:  1996-12       Impact factor: 17.440

4.  Blood lactate and mixed venous-arterial PCO2 gradient as indices of poor peripheral perfusion following cardiopulmonary bypass surgery.

Authors:  M Ariza; J W Gothard; P Macnaughton; J Hooper; C J Morgan; T W Evans
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

5.  Basic arterial blood gas biomarkers as a predictor of mortality in tetralogy of Fallot patients.

Authors:  Vandana Bhardwaj; Poonam Malhotra Kapoor; Kalpana Irpachi; Suruchi Ladha; Ujjwal Kumar Chowdhury
Journal:  Ann Card Anaesth       Date:  2017 Jan-Mar

6.  The metabolic and renal effects of adrenaline and milrinone in patients with myocardial dysfunction after coronary artery bypass grafting.

Authors:  Matthias Heringlake; Marit Wernerus; Julia Grünefeld; Stephan Klaus; Hermann Heinze; Matthias Bechtel; Ludger Bahlmann; Jochen Poeling; Julika Schön
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

7.  Modified Glucose-Insulin-Potassium Regimen Provides Cardioprotection With Improved Tissue Perfusion in Patients Undergoing Cardiopulmonary Bypass Surgery.

Authors:  Kun Zhao; Yue Zhang; Jia Li; Qin Cui; Rong Zhao; Wensheng Chen; Jincheng Liu; Bijun Zhao; Yi Wan; Xin-Liang Ma; Shiqiang Yu; Dinghua Yi; Feng Gao
Journal:  J Am Heart Assoc       Date:  2020-03-10       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.